The growth hormone secretagogue family is one of the most studied groups in peptide research — and one of the most frequently confused, because its members work through two entirely different receptor systems. Understanding the split is essential for designing clean studies of the somatotropic axis.
Pathway One: GHRH Receptor Analogs
The first group mimics growth hormone-releasing hormone, the hypothalamic signal that instructs pituitary somatotrophs to release growth hormone. Members differ mainly in stability:
- Sermorelin — the 1-29 fragment of native GHRH, the shortest fully active sequence, with a naturally brief, pulsatile profile
- Tesamorelin — the complete GHRH sequence stabilized with a trans-3-hexenoic acid group for extended activity
- CJC-1295 — a modified analog engineered for substantially longer half-life through cleavage-resistant substitutions
Pathway Two: Ghrelin Receptor (GHS-R) Agonists
The second group works through the growth hormone secretagogue receptor — the ghrelin receptor — a completely separate signaling route:
- Ipamorelin — prized in research for selectivity, stimulating GH release with minimal influence on cortisol or prolactin in published preclinical work
- GHRP-6 — an earlier-generation hexapeptide that also engages ghrelin-linked appetite pathways, making it a dual-purpose research probe
Why Combination Designs Dominate the Literature
Because the two pathways converge on the same endpoint through different receptors, pairing one compound from each class is a classic study design for examining synergistic release. Pre-combined research blends like CJC-1295 (No DAC) with Ipamorelin and Tesamorelin with Ipamorelin package the two mechanisms in a single vial for combination protocols.
Sourcing for Axis Research
Our full Growth Hormone Secretagogue collection spans both pathways, every batch third-party verified at 99%+ purity with COA documentation.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.
